Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Zanger

Showing results (61-70 of 203) with videos related to

Pageof 21
Sort By:
Drug Metabolism and Disposition: the Biological Fate of Chemicals|March 9, 2007
Molecular mechanism of basal CYP3A4 regulation by hepatocyte nuclear factor 4alpha: evidence for direct regulation in the intestineHeike Tegude, Anke Schnabel, Ulrich M Zanger, et al.
Progress in Liver Diseases|January 1, 1990
Genetic polymorphisms of drug metabolismU A Meyer, U M Zanger, R C Skoda, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|February 11, 2009
A predominate role of CYP1A2 for the metabolism of nabumetone to the active metabolite, 6-methoxy-2-naphthylacetic acid, in human liver microsomesMiia Turpeinen, Ute Hofmann, Kathrin Klein, et al.
The Journal of Biological Chemistry|February 25, 1993
Cooperating nonconsensus cAMP-responsive elements are mediators of adrenocorticotropin-induced VL30 transcription in steroidogenic adrenal cellsS Bohm, M Bakke, M Nilsson, et al.
Cellular Physiology and Biochemistry : International Journal of Experimental Cellular Physiology, Biochemistry, and Pharmacology|July 12, 2014
Targeting nuclear receptors with lentivirus-delivered small RNAs in primary human hepatocytesMaria Thomas, Jessica K Rieger, Benjamin A Kandel, et al.
Pharmacogenetics|October 1, 1996
Rapid detection of CYP2D6 null alleles by long distance- and multiplex-polymerase chain reactionT Stüven, E U Griese, H K Kroemer, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|December 7, 2014
A systematic comparison of the impact of inflammatory signaling on absorption, distribution, metabolism, and excretion gene expression and activity in primary human hepatocytes and HepaRG cellsMarcus Klein, Maria Thomas, Ute Hofmann, et al.
The Pharmacogenomics Journal|November 5, 2003
Influence of CYP2C9 genotypes on the formation of a hepatotoxic metabolite of valproic acid in human liver microsomesP C Ho, F S Abbott, U M Zanger, et al.
Xenobiotica; the Fate of Foreign Compounds in Biological Systems|January 1, 1996
Immunohistochemical assessment of human microsomal epoxide hydrolase in primary and secondary liver neoplasm: a quantitative approachP Fritz, E Behrle, U M Zanger, et al.
Naunyn-Schmiedeberg'S Archives of Pharmacology|July 3, 2004
Limited contribution of CYP3A5 to the hepatic 6beta-hydroxylation of testosteroneLandry K Kamdem, Ingolf Meineke, Ina Koch, et al.
Pageof 21

Showing results (61-70 of 203) with videos related to

Sort By:
Pageof 21
Drug Metabolism and Disposition: the Biological Fate of Chemicals|March 9, 2007
Molecular mechanism of basal CYP3A4 regulation by hepatocyte nuclear factor 4alpha: evidence for direct regulation in the intestineHeike Tegude, Anke Schnabel, Ulrich M Zanger, et al.
Progress in Liver Diseases|January 1, 1990
Genetic polymorphisms of drug metabolismU A Meyer, U M Zanger, R C Skoda, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|February 11, 2009
A predominate role of CYP1A2 for the metabolism of nabumetone to the active metabolite, 6-methoxy-2-naphthylacetic acid, in human liver microsomesMiia Turpeinen, Ute Hofmann, Kathrin Klein, et al.
The Journal of Biological Chemistry|February 25, 1993
Cooperating nonconsensus cAMP-responsive elements are mediators of adrenocorticotropin-induced VL30 transcription in steroidogenic adrenal cellsS Bohm, M Bakke, M Nilsson, et al.
Cellular Physiology and Biochemistry : International Journal of Experimental Cellular Physiology, Biochemistry, and Pharmacology|July 12, 2014
Targeting nuclear receptors with lentivirus-delivered small RNAs in primary human hepatocytesMaria Thomas, Jessica K Rieger, Benjamin A Kandel, et al.
Pharmacogenetics|October 1, 1996
Rapid detection of CYP2D6 null alleles by long distance- and multiplex-polymerase chain reactionT Stüven, E U Griese, H K Kroemer, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|December 7, 2014
A systematic comparison of the impact of inflammatory signaling on absorption, distribution, metabolism, and excretion gene expression and activity in primary human hepatocytes and HepaRG cellsMarcus Klein, Maria Thomas, Ute Hofmann, et al.
The Pharmacogenomics Journal|November 5, 2003
Influence of CYP2C9 genotypes on the formation of a hepatotoxic metabolite of valproic acid in human liver microsomesP C Ho, F S Abbott, U M Zanger, et al.
Xenobiotica; the Fate of Foreign Compounds in Biological Systems|January 1, 1996
Immunohistochemical assessment of human microsomal epoxide hydrolase in primary and secondary liver neoplasm: a quantitative approachP Fritz, E Behrle, U M Zanger, et al.
Naunyn-Schmiedeberg'S Archives of Pharmacology|July 3, 2004
Limited contribution of CYP3A5 to the hepatic 6beta-hydroxylation of testosteroneLandry K Kamdem, Ingolf Meineke, Ina Koch, et al.
Pageof 21